1. Home
  2. YMAT vs YI Comparison

YMAT vs YI Comparison

Compare YMAT & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAT
  • YI
  • Stock Information
  • Founded
  • YMAT 1970
  • YI 2010
  • Country
  • YMAT Taiwan
  • YI China
  • Employees
  • YMAT N/A
  • YI N/A
  • Industry
  • YMAT Recreational Games/Products/Toys
  • YI Retail-Drug Stores and Proprietary Stores
  • Sector
  • YMAT Consumer Discretionary
  • YI Consumer Staples
  • Exchange
  • YMAT Nasdaq
  • YI Nasdaq
  • Market Cap
  • YMAT 76.4M
  • YI 70.0M
  • IPO Year
  • YMAT 2025
  • YI N/A
  • Fundamental
  • Price
  • YMAT N/A
  • YI $6.92
  • Analyst Decision
  • YMAT
  • YI
  • Analyst Count
  • YMAT 0
  • YI 0
  • Target Price
  • YMAT N/A
  • YI N/A
  • AVG Volume (30 Days)
  • YMAT 2.0M
  • YI 7.2K
  • Earning Date
  • YMAT 01-01-0001
  • YI 08-28-2025
  • Dividend Yield
  • YMAT N/A
  • YI N/A
  • EPS Growth
  • YMAT N/A
  • YI N/A
  • EPS
  • YMAT 0.07
  • YI N/A
  • Revenue
  • YMAT $17,563,985.00
  • YI $1,984,717,013.00
  • Revenue This Year
  • YMAT N/A
  • YI N/A
  • Revenue Next Year
  • YMAT N/A
  • YI N/A
  • P/E Ratio
  • YMAT $64.10
  • YI N/A
  • Revenue Growth
  • YMAT N/A
  • YI N/A
  • 52 Week Low
  • YMAT $3.80
  • YI $4.15
  • 52 Week High
  • YMAT $4.88
  • YI $11.90
  • Technical
  • Relative Strength Index (RSI)
  • YMAT N/A
  • YI 34.54
  • Support Level
  • YMAT N/A
  • YI $6.69
  • Resistance Level
  • YMAT N/A
  • YI $7.05
  • Average True Range (ATR)
  • YMAT 0.00
  • YI 0.20
  • MACD
  • YMAT 0.00
  • YI -0.04
  • Stochastic Oscillator
  • YMAT 0.00
  • YI 23.96

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: